Literature DB >> 2156001

Passive immunization protects the mouse eye from damage after herpes simplex virus infection by limiting spread of virus in the nervous system.

C Shimeld1, T J Hill, W A Blyth, D L Easty.   

Abstract

Mice were treated with serum containing antibodies to herpes simplex virus type 1 (HSV-1) or normal serum, 1 day before inoculation on the cornea with HSV-1 strain McKrae. As expected, without passive immunization, mice developed high levels of serum neutralizing antibody. By contrast, in passively immunized animals, such antibody became undetectable by 29 days after inoculation of serum, in spite of the virus infection. There was no difference between passively immunized mice and those given normal serum in the duration of shedding of virus in tears and the duration and severity of corneal epithelial disease. However, non-immunized mice had a high incidence of mortality and developed disease of the iris, corneal stroma and lids, and their corneas became opaque and vascularized. In non-immunized animals, the timing of isolation of virus from nervous tissues and the sequence of appearance of virus antigens in ocular tissues indicate that the disease of deeper eye tissue was caused by virus spreading from the nervous system back to the eye. Restriction of such spread in passively immunized animals seems the likely explanation for their protection from death and severe ocular damage. Despite this restricted spread, passively immunized animals had a high incidence of latent infection in the ophthalmic part of the trigeminal ganglion. However, in comparison with mice given normal serum, there was a far lower incidence of such infection in the other two parts of this ganglion and in the superior cervical ganglion. Since passively immunized animals have a high incidence of latent infection in the ophthalmic part of the trigeminal ganglion and their eyes are normal, they will prove useful in studies involving induction of recurrent disease.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2156001     DOI: 10.1099/0022-1317-71-3-681

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  19 in total

1.  Pathogenesis of herpes simplex virus-induced ocular immunoinflammatory lesions in B-cell-deficient mice.

Authors:  S P Deshpande; M Zheng; M Daheshia; B T Rouse
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

2.  Acute and latent infection of mice immunised with HSV-1 ISCOM vaccine.

Authors:  M Erturk; T J Hill; C Shimeld; R Jennings
Journal:  Arch Virol       Date:  1992       Impact factor: 2.574

3.  Social stress and the reactivation of latent herpes simplex virus type 1.

Authors:  D A Padgett; J F Sheridan; J Dorne; G G Berntson; J Candelora; R Glaser
Journal:  Proc Natl Acad Sci U S A       Date:  1998-06-09       Impact factor: 11.205

4.  Therapeutic immunization with a virion host shutoff-defective, replication-incompetent herpes simplex virus type 1 strain limits recurrent herpetic ocular infection.

Authors:  Tammie L Keadle; Lynda A Morrison; Jessica L Morris; Jay S Pepose; Patrick M Stuart
Journal:  J Virol       Date:  2002-04       Impact factor: 5.103

5.  Herpes simplex virus-induced keratitis: evaluation of the role of molecular mimicry in lesion pathogenesis.

Authors:  S P Deshpande; S Lee; M Zheng; B Song; D Knipe; J A Kapp; B T Rouse
Journal:  J Virol       Date:  2001-04       Impact factor: 5.103

6.  The role of the immune system in establishment of herpes simplex virus latency--studies using CD4+ T-cell depleted mice.

Authors:  D S Schmidt; A M Eis-Hübinger; K E Schneweis
Journal:  Arch Virol       Date:  1993       Impact factor: 2.574

7.  Recurrent herpetic stromal keratitis in mice, a model for studying human HSK.

Authors:  Jessica Morris; Patrick M Stuart; Megan Rogge; Chloe Potter; Nipun Gupta; Xiao-Tang Yin
Journal:  J Vis Exp       Date:  2012-12-18       Impact factor: 1.355

8.  CD28 Costimulation Is Required for Development of Herpetic Stromal Keratitis but Does Not Prevent Establishment of Latency.

Authors:  Xiao-Tang Yin; Nicholas K Baugnon; Chloe A Potter; Shannon Tai; Tammie L Keadle; Patrick M Stuart
Journal:  J Virol       Date:  2019-07-30       Impact factor: 5.103

9.  The role of neutralizing antibody and T-helper subtypes in protection and pathogenesis of vaccinated mice following ocular HSV-1 challenge.

Authors:  H Ghiasi; S L Wechsler; S Cai; A B Nesburn; F M Hofman
Journal:  Immunology       Date:  1998-11       Impact factor: 7.397

10.  Herpes simplex virus type 1 mutant strain in1814 establishes a unique, slowly progressing infection in SCID mice.

Authors:  T Valyi-Nagy; S L Deshmane; B Raengsakulrach; M Nicosia; R M Gesser; M Wysocka; A Dillner; N W Fraser
Journal:  J Virol       Date:  1992-12       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.